24/02/2021 - Research

SNCA transcripts found in blood are candidate biomarkers for Lewy body dementia and Parkinson disease

In a new study published in the Journal of Molecular Science, the Genomics and Transcriptomics of Synucleinopathies Group, led by Dr Katrin Beyer, have got one step nearer to finding a reliable biomarker to differentiate between Lewy body dementia and Parkinson disease in the early stages, when symptoms are very similar. Correct diagnosis is extremely difficult, but essential for these patients as the wrong treatment can have very serious effects.

19/02/2021 - Research

The Barcelona Medical Photonics Network: united to improve the health and well-being of society

As the research institute of the Germans Trias i Pujol Hospital, the IGTP is one of 8 health research institutes that has joined the ICFO to consolidate a state-of-the-art bench to bedside Barcelona Photonics Technology Network. The Medical Photonics Network of Barcelona was presented on 18 February, it aims to promote the research and development activities in photonics being carried out in the Barcelona area by formalizing the long-running relationship between the ICFO and its biomedical and clinical partners.

08/02/2021 - Campus Can Ruti, Research

Blocking the spread of HIV or favouring the spread of the tuberculosis bacteria, the flip side of the Siglec-1 protein's absence

In 2016, the Retrovirology and Clinical Studies group at IrsiCaixa discovered how the absence of the Siglec-1 protein, involved in modulating the immune system, blocks the spread of HIV throughout the body. Now, a study led by the same research group and the Experimental Tuberculosis Unit of the Germans Trias i Pujol Research Institute (IGTP) has shown that, on the other hand, this same deficiency favours the dissemination of Mycobacterium tuberculosis (Mtb), the tuberculosis-causing agent. 

29/01/2021 - Research

The CMCiB contributes to a new e-book on researcher and animal safety

A new e-book published by the Journal Laboratory Equipment, called Safe and Effective Research in the Vivarium features a case study from the Centre for Comparative Medicine and Bioimage of the IGTP (CMCiB-IGTP). Staff from the CMCiB have provided expert advice on aspects of safety.

28/01/2021 - Research

A pilot study reveals that natural killer cells could track the progress of type 1 diabetes

The Immunology of Diabetes Group, led by Marta Vives-PI has shown that levels of 4 subtypes of natural killer (NK) cells in the blood of Type 1 Diabetes patients change through different stages of the disease. These cells have a complex role in the immune attack during T1D and have been implicated in both the destruction and protection of insulin-producing cells. This pilot study, published in Frontiers in Immunology, tracks the levels of 4 subtypes of NK cells and suggests that these cells are good candidate biomarkers for disease progression.

11/12/2020 - Innovation, Research

Two IGTP spin-off companies receive the European Commission’s Seal of Excellence

Two spin-off companies of the Germans Trias I Pujol Research Institute (IGTP) Biointaxis and Time is Brain have received the Seal of Excellence from the European Commission. The two companies with IGTP participation have opted for financing from the Horizon 2020 Programme and the award puts them in an advantageous position when requesting funds from other funding bodies.

11/12/2020 - Research

An interactomic study identifies a protein as a possible new therapeutic target to prevent neurodegeneration after stroke

A group of researchers led from the Germans Trias i Pujol Institute have conducted an in-depth in-vitro study into the DAPK1 interactome during stroke conditions. They have identified the proteins in the DAPK1 interactome and singled out LRRFIP1 as a possible therapeutic target for neuroprotection after stroke. The study is published in Antioxidants.

10/12/2020 - Research

Two studies show the way ahead for better non-invasive monitoring of kidney transplants

Members of the Kidney-affecting Diseases Research Group and the Innovation in Vesicles and Cells for Application in Therapy (REMAR-IVECAT) have recently published two studies led by Dr Francesc E. Borràs, which identify possible biomarkers of irreversible damage to transplanted kidneys; a pathology that eventually causes them to stop working. The papers have been published in the International Journal of Molecular Science and the Journal of Nephrology.

27/11/2020 - Research

The IGTP Participates in 3 Projects funded by the 2019 Edition of La Marató

The Germans Trias i Pujol Research Institute (IGTP) has received a total of 305,680 euros for three projects on rare diseases in which it participates or coordinates. In total the three projects have received financing of more than a million euros, to be divided between the several institutions participating. This edition of the fundraising marathon will fund a total of 41 biomedical research projects of excellence on rare diseases. The projects aim to provide better diagnosis at birth and provide more efficient and safer treatments to improve quality of life and extend the lifespans of people affected.

25/11/2020 - Research

Protein or mRNA? Which will be the future for TB diagnosis?

In a study published in the Journal of Clinical Microbiology members of the Innovation in Respiratory Infections and Tuberculosis Diagnosis Group tested a new diagnostic technique developed in Denmark. The technique performed to similar standards as the tests currently in use. Researchers are aiming to develop a better tool to detect latent cases of tuberculosis (TB).